Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities

Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities

Ruidi Jiao,*,1 Hui Luo,*,1 Wenbo Xu,2 Hong Ge11Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province 450008, People’s Republic of China; 2Department of Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, H...

Full description

Bibliographic Details
Main Authors: Jiao R, Luo H, Xu W, Ge H
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:OncoTargets and Therapy
Subjects:
esophageal squamous cell carcinoma (ESCC)
immune checkpoint inhibitors
biomarkers
research progress
Online Access:https://www.dovepress.com/immune-checkpoint-inhibitors-in-esophageal-squamous-cell-carcinoma-pro-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/immune-checkpoint-inhibitors-in-esophageal-squamous-cell-carcinoma-pro-peer-reviewed-article-OTT

Similar Items